A Quality-by-Design Approach to Optimize In-Process Curing of EUDRAGIT NM 30 D

A study investigated the influence and correlation of critical process parameters for the optimization of in-process curing.

Previous studies with EUDRAGIT NM 30 D showed that storage stability can be achieved with in-process curing at specific conditions. The aim of this study was to identify and investigate the influence and correlation of critical process parameters for the optimization of in-process curing.

Download

Pharmaceutical Technology’s 2014 Solid Dosage and Excipients eBook

.

Articles in this issue

over 12 years ago

Article

Safety by Design—Mitigating the Risk of Medication Errors Through Product Design

over 12 years ago

Article

Controlled-Release Technologies Create Opportunities for Solid-Dosage Drug Formulators

over 12 years ago

Article

Continuous Manufacturing for Solid-Dosage Drug Production

over 12 years ago

Article

A Practical Guide to Hot-Melt Extrusion Scale-Up for Pharmaceutical Applications

over 12 years ago

Article

Using Modular Systems in Solid-Dosage Manufacturing

over 12 years ago

Article

Advances in Hot-Melt Extrusion Manufacturing

over 12 years ago

Article

Obtaining User-Defined Particle Size Distribution Using Dry Granulation

over 12 years ago

Article

Selection of Excipients in Generic Formulations

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.